HALEON PLC (HLN)

London
Currency in GBP
Disclaimer
340.45
+7.35(+2.21%)
Real-time Data
Day's Range
333.25341.45
52 wk Range
263.15357.65
Bid/Ask
340.45 / 340.55
Prev. Close
333.1
Open
334
Day's Range
333.25-341.45
52 wk Range
263.15-357.65
Volume
2,627,970
Average Volume (3m)
11,451,699
1-Year Change
19.52%
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
358.59
Upside +5.48%

People Also Watch

2,084.00
HIK
+0.24%
242.80
MONY
+1.34%
2,794.00
REL
+1.08%
1,649.5
JMAT
+3.48%
1.720
ICAG
+0.79%

HALEON PLC Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.

Employees
24622

Income Statement